Strong Growth, Dented Margins: How Excelsoft's FY27 Outlook Broke the Market's Patience

On the revenue screen, Excelsoft nailed it: ₹80.3 crore in Q1 is a clean 44% year-on-year jump, with PAT up 57% to ₹9.2 crore. But the street's 11% sell-off by day 5 was not about missing growth. It was about what management just telegraphed on margins. The company cut its FY27 EBITDA margin guidance from 30-31% (the prior call's assurance) all the way down to 24-25%. That's 600 basis points of retrenchment, and it says: 'the growth isn't coming with the profitability we once promised.'

Q1's EBITDA margin of 16.2% is down 178 basis points from 18.0% the year before. Management cited ₹1.46 crore in one-time costs for the US nearshore team build-out, which sounds cushiony—but it only explains about 40 basis points of the decline. The other 138 basis points are structural: sales team expansion, nearshore capacity building, and AI-native product investments that won't fully unwind. Management's honest trade-off: 'We prefer 30%+ revenue growth at 25% margins over slower growth at higher margins.' In other words, they're betting growth will eventually drive fixed-cost leverage. The question is whether that bet plays out before the market's patience runs out.

Three big shifts landed this quarter. First, margin guidance retreated: last call, management signaled a return to 30-31% EBITDA margins as one-time US nearshore costs wound down. Now: 24-25% for FY27, with no timeline to recover. The gap is real and structural—sales expansion, nearshore capacity, and AI product development are not temporary. Second, nearshore pivoted from pilot to production: what was a small-scale initiative last quarter is now material at ₹10 crore in Q1 revenue (26% margin) with a ₹40 crore annual order book in flight. The mechanism is de-risked, but execution is not—margins need to ramp to 35-40% for the expansion story to work. Third, AQA escalated: previously an 'engagement signed, work in progress' milestone, now ₹2.5 crore booked in Q1, ₹12-15 crore expected FY27, and a credible USD 17 million four-year visibility. This moves from promise to delivery, and will make AQA the company's second-largest account.

The market's initial reaction was blunt: -7.14% on day 1, widening to -11.58% by day 5. This is not a pop-and-fade—it's a consistent repricing. The stock closed the pre-result day at ₹83.65; it's now at ₹72.59, down 13% in absolute terms since the announcement. Contextually, the stock is trading 49% below its all-time high of ₹142.59, and it's sitting below all key moving averages (SMA20 ₹77.44, SMA50 ₹78.19). The RSI of 38.6 suggests oversold territory, but not yet capitulation.

Institutional flows are negative. FII ownership fell from 1.37% in Q4 to 1.12% in Q1 (a 25-basis-point exit). DII stepped back from 4.05% to 3.10% (95 basis points). Both the foreign and domestic smart money are trimming, not adding—a signal that the growth story alone isn't compelling without margin visibility. There were no significant insider trades or block deals flagged; the sell-off is broad-based institutional lightening, not panic selling by promoters.

The thesis the market was pricing before the result: high-growth, margin-accretive EdTech play returning to 30%+ EBITDA margins. The thesis now: high-growth, margin-trapped in the mid-20s, with execution risk on nearshore and AQA ramps. The 11% repricing is the market saying, 'That trade doesn't work unless margins inflect visibly in Q2 or the full-year guides beat.'